NCT06717334View on ClinicalTrials.gov

A Study of Lung Cancer Screening in People With Unexplained Weight Loss

RecruitingOBSERVATIONAL
Enrollment

409

Participants

Timeline

Start Date

December 2, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Lung Cancer Screening
Interventions
DIAGNOSTIC_TEST

Low Dose CT imaging

at baseline and at Year 1.

OTHER

blood draws

at baseline and at Year 1.

OTHER

screening questionnaire

at baseline and at 1 year after registration.

Trial Locations (8)

10065

RECRUITING

Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York

10467

NOT_YET_RECRUITING

Montefiore Health Systems (Montefiore Medical Center), The Bronx

10604

RECRUITING

Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison

11553

RECRUITING

Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale

11725

RECRUITING

Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities), Commack

07920

RECRUITING

Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge

07748

RECRUITING

Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown

07645

RECRUITING

Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Memorial Sloan Kettering Cancer Center

OTHER